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Background: Women with previous gestational diabetes mellitus (pGDM) face a higher risk of developing type 2
diabetes and, consequently, a higher cardiovascular risk. This study aimed to compare the carotid intima-media
thickness (cIMT) from young women with pGDM to those with metabolic syndrome (MS) and to healthy controls
(CG) to verify whether a past history of pGDM could be independently associated with increased cIMT.
Methods: This is a cross-sectional study performed in two academic referral centers. Seventy-nine women with
pGDM, 30 women with MS, and 60 CG aged between 18 and 47 years were enrolled. They all underwent physical
examination and had blood glucose, total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein
cholesterol (LDLc), and triglycerides determined. The cIMT was measured by ultrasound in several carotid segments.
The primary endpoint was cIMT and clinically relevant parameters included as predictors were: age, systolic blood
pressure, waist, BMI, total cholesterol, LDLc, triglycerides, fasting glucose, previous history of GDM as a whole group,
previous history of GDM without MS, presence of DM, presence of MS, and parity.
Results: cIMT was significantly higher in pGDM when compared to CG in all sites of measurements (P< 0.05)
except for the right common carotid. The pGDM women showed similar cIMT measurements to MS in all sites of
measurements, except for the left carotid bifurcation, where it was significantly higher than MS (P< 0.001). In a
multivariate analysis which included classical cardiovascular risk factors and was adjusted for confounders, pGDM
was shown to be independently associated with increased composite cIMT (P< 0.01). The pGDM without risk
factors further showed similar cIMT to MS (P> 0.05) and an increased cIMT when compared to controls (P< 0.05).
Conclusions: Previous GDM was independently associated with increased composite cIMT in this young
population, similarly to those with MS and regardless the presence of established cardiovascular risk factors.
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Gestational diabetes mellitus (GDM) is a carbohydrate
intolerance detected during pregnancy and its preva-
lence rate varies between 1-14% [1]. Besides the well-
known impact of GDM for the fetus, its effects after
pregnancy have been acknowledged [2]. A recent meta-
analysis showed a 7.5 times increase in the risk of type 2
diabetes in women with previous GDM and this risk was
shown to increase even further when these women were
examined more than 5 years postpartum [3]. Besides an
increased risk of carbohydrate metabolism disturbances,
this population has an increased cardiovascular risk due
to clustering of other cardiovascular risk factors such as
increased prevalence of metabolic syndrome (MS).
However, the presence of known atherosclerotic risk
factors may not completely explain the cardiovascular
burden in some populations [4,5].
Carotid intima-media thickness (cIMT) measured by
ultrasound is an inexpensive test to assess the presence of
subclinical atherosclerosis. It assesses the atherosclerotic
disease process itself, which includes the net effect of
hereditary and environmental factors, either known or yet
to be discovered [6]. Moreover, cIMT has been considered
an independent predictor of future cardiovascular events
such as stroke and coronary artery disease, and it has been
used as a surrogate end point in many clinical trials and
epidemiological studies [7].
This study aimed to determine whether young
women with previous GDM show signs of subclinical
atherosclerosis, and whether it could be similar to
those with MS. To this purpose, cIMT of pGDM was
compared to cIMT of young women with metabolic
syndrome (MS) and to young healthy controls.
Methods
Hundred sixty-nine women were enrolled in this study
protocol. Seventy-nine non-smoking and non-menopausal
women aged between 18 and 47 years were referred to the
Endocrinology Outpatient Clinics of Federal University of
Minas Gerais and to Odete Valadares Maternity,
32.51± 2.60 months after pregnancies complicated by
GDM (pGDM group). They comprised a convenient out-
patient sample that had been followed in the outpatient
clinics of these both institutions when they had their preg-
nancies complicated by gestational diabetes. For this
pGDM group, any past condition afflicting them at
previous pregnancies, other than GDM, was considered
an exclusion criteria, especially those requiring hospital
admission such as preeclampsia. Thirty non-smoking and
non-menopausal patients without previous GDM but with
confirmed metabolic syndrome (MS), and 60 healthy non-
smoking women within the same age range were enrolled
as controls (CG). These two last populations were also
derived from the same institutions. Subjects withalcoholism, drug addiction, uremia as well as those with
liver, psychiatric, rheumatologic, and thyroid diseases or in
use of corticosteroids, were promptly excluded from this
protocol.
The diagnosis of GDM was performed as recommended
by the American Diabetes Association [8] and risk factors
were defined as recommended by the Framingham Study
[9], adding body mass index (BMI) and waist [10]. Hyper-
tension was defined according to VII Report of the Joint
National Committee on prevention, detection, evaluation
and treatment of high blood pressure [11]. For the diagno-
sis of MS, the definition of the American Heart Associ-
ation and National Heart Lung and Blood Institute, in
which they recommend the Adult Treatment Panel III
with minor modifications, was adopted. The combination
of three of the following five were used for the diagnosis of
MS: waist circumference≥ 88 cm, triglycerides ≥150 mg/dl
or on medication for high triglycerides, high-density lipo-
protein cholesterol (HDLc) <50 mg/dl or drug treatment
to raise HDLc, blood pressure ≥130/85 mmHg or treat-
ment with antihypertensive medications in a patient with a
history of hypertension, and fasting glucose ≥100 mg/dl or
drug treatment for hyperglycemia [12].
All participants underwent a thorough physical exam-
ination, including the measure of body mass index
(BMI) and waist. All medications in use were recorded.
They were particularly inquired on their family histories
for coronary disease and of current use of hormonal
contraceptives. The Framingham’s global cardiovascular
risk score (FRS) was estimated to all of them. The risk
factors evaluated for the FRS were age, total cholesterol
and HDLc, systolic blood pressure, treatment for hyper-
tension, and diabetes status [9].
Laboratory measurements
Fasting glucose, total cholesterol, HDLc, and triglycerides
were all assayed in duplicate. Samples were measured
through standard techniques (BIOCLIN, Quibasa,
Belo Horizonte, Brazil), and low-density lipoprotein
cholesterol (LDLc) was calculated by Friedewald for-
mula as triglycerides was lower than 400mg/dl in all
samples.
Ultrasound study
A GE Health Care Vivid 7 Dimension (Wauwatosa, WI,
USA) high-resolution ultrasound scanner with a high
frequency (7. 10 or 12 MHZ) linear array transducer was
used for cIMT measurement. The examination of the
carotid arteries comprised automated measurements of
cIMT in selected segments of the far wall: 1cm distal to
the flow divider in proximal internal carotid (IC), 1cm
proximal to the flow divider as bifurcation (BIF), and
2cm or more proximal to the flow divider in common
carotid (CC) bilaterally, as recommended by American
Table 1 Comparisons of clinical and biochemical








Age (years) 36.42 ± 0.61 37.97 ± 1.14 34.78 ± 0.88 NS
BMI (kg/m2) 29.01 ± 0.66 33.32 ± 1.26 22.46 ± 0.42 <0.001}&*
Waist (cm) 92.09 ± 1.63 103.63 ± 2.48 74.08 ± 1.14 <0.001}&*
Systolic 120.81 ± 1.89 125.67 ± 2.43 112.27 ± 1.02 <0.001&*
BP (mmHg)




110.32 ± 5.99 104.96 ± 3.36 84.85 ± 1.06 <0.001&*
Total Cholesterol 189.72 ± 5.09 200.32 ± 8.61 171.86 ± 3.74 0.001&*
(mg/dl)
HDLc (mg/dl) 49.71 ± 1.83 45.22 ± 2.17 59.19 ± 1.72 <0.001&*
LDLc(mg/dl) 114.21 ± 4.50 123.75 ± 9.39 94.98 ± 3.63 0.001&*
Triglycerides 142.05 ± 15.23 177.73 ± 18.50 75.58 ± 3.74 <0.001&*
(mg/dl)
Data are shown as means ± SEM. pGDM = previous gestational diabetes
group; MS = metabolic syndrome group; CG = controls; NS = not significant;
BMI = body mass index; BP = blood pressure; HDLc = high-density lipoprotein
cholesterol; LDLc = low-density lipoprotein cholesterol; &for comparisons
of pGDM to CG; }for comparisons of pGDM to MS; *for comparisons of MS
to CG.
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average of 243 points for common carotid, and an aver-
age of 190 points for internal carotid and bifurcation.
The ultrasonographic examination was performed by the
same physician (CMVF) blinded to the clinical and
metabolic status of the participants, as published else-
where [14]. The images were checked by another experi-
enced ultrasonographer (MCCA), and the inter-observer
coefficient of variation was less than 10%. To quantify
for the degree of thickening of the carotid artery walls,
the average of the mean cIMT of the three right and
three left far wall segments was used to determine the
composite cIMT values. As both composite and single
measurements have been currently reported in the
literature, we have shown both. However, as composite
values are representative of the whole measurements, we
have chosen the composite approach to the stepwise
regression model.
Statistical analysis
Statistical analysis was performed using SPSS for
Windows (Statistical Package for the Social Sciences,
Version 17; SPSS, Inc., Chicago, IL, USA). Variables
were tested for normality by Shapiro-Wilk test. Con-
tinuous data were presented as means ± standard
error of the means (SEM) or medians [interquartile
ranges], as appropriate. The categorical data were
shown as percentage and compared by the chi-square
test or the Fisher's exact test whenever the sample
sizes were rather small. The clinical, biochemical
characteristics and cIMT were compared by Kruskal-
Wallis or one-way ANOVA, as appropriate, followed
by Bonferroni correction.
We developed a model of multiple linear regression
(stepwise selection method, taking P <0.1) using com-
posite cIMT as the dependent variable and clinically
relevant parameters as predictors (age, systolic blood
pressure, waist, BMI, total cholesterol, LDLc, triglycer-
ides, fasting glucose, previous history of GDM as a
whole group, previous history of GDM without MS,
presence of DM, presence of MS, and parity). Further-
more, as there was a significant number of women in
pGDM group that also had metabolic syndrome, this
group was broken down into three (pGDM without risk
factor, pGDM with 1 or 2 risk factors, and MS positive)
and compared by ANOVA followed by Bonferroni correc-
tion to the other groups. A P-value of <0.05 was taken as
significant.
Ethics
All participants signed an informed consent before any
procedure related to this study. The institutional Ethical
Committees approved the investigational protocol
(CAAE – 0455–06).Results
The clinical, biochemical, and cIMT characteristics of the
studied groups are shown in Tables 1 and 2, respectively.
There were no significant differences in age among groups
(P> 0.05) Patients from pGDM and MS groups showed
significantly higher BMI and waist when compared to CG
(P< 0.001 for both comparisons). Likewise, systolic and
diastolic blood pressures, fasting glucose, total cholesterol,
LDLc, and triglycerides were higher in pGDM and MS
when compared to controls (P< 0.001 for all compari-
sons) whereas HDLc from these two groups was lower
than CG (P< 0.001for both comparisons). However, the
comparisons between pGDM and MS showed that both
BMI and waist were significantly higher in the MS group
(P< 0.001 for both comparisons).
Mean cIMT was significantly higher in pGDM when
compared to CG in all sites of measurements (P< 0.05
for all measurements), except in the right common ca-
rotid where no significant differences could be detected.
Interestingly, pGDM and MS showed similar cIMT mea-
sures in the left common and in the left internal carotid,
besides all right carotid measurements and composite
cIMT. However, cIMT was higher in pGDM than MS in
the left carotid bifucartion (P< 0.01). MS showed thicker
cIMT than controls in the composite (P< 0.001) and
right bifurcation measurements (P< 0.05).
Table 2 Comparisons of measurements of cIMT for each
group of subjects







LCC mean 0.53 0.55 0.50 <0.05&
[0.49-0.58] [0.46-0.59] [0.46-0.55]
LBIF mean 0.61 0.58 0.57 0.001}&
[0.54-0.69] [0.50-0.64] [0.50-0.61]
LIC mean 0.45 0.43 0.40 0.01&
[0.38-0.52] [0.36-0.50] [0.32-0.47]
RCC mean 0.51 0.52 0.50 NS
[0.46-0.56] [0.48-0.62] [0.46-0.54]
RBIF mean 0.59 0.59 0.55 <0.05&*
[0.51-0.63] [0.52-0.66] [0.48-0.60]
RIC mean 0.45 0.42 0.40 <0.05&
[0.39-0.56] [0.34-0.52] [0.36-0.50]
Composite IMT 0.53 0.53 0.49 <0.001&*
[0.48-0.57] [0.48-0.57] [0.45-0.53]
Data are shown as medians [P25-P75]. pGDM = previous gestational diabetes group;
MS = metabolic syndrome group; CG = controls; NS = not significant; R = right; L =
left; CC = common carotid; BIF = bifurcation; IC = internal carotid; & for comparisons
of pGDM to CG; } for comparisons of pGDM to MS; *for comparisons of MS to CG.
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patients from MS (13.33%) were categorized in the inter-
mediate risk category according to FRS (P> 0.05). All
patients from CG were categorized as low risk according
to FRS. None of the patients were categorized in the
high risk group.
The pGDM group was a heterogeneous group with
respect to the presence of cardiometabolic risk factors. It
comprised 15 women with normal cardiovascular profile,
33 women with established MS (three or more features
for MS diagnosis) and the others had 1 or 2 risk factors
for MS. Therefore, we have divided the pGDM for the
purpose of graphic representation of composite cIMT
into three subgroups, according to the presence of risk
factors or established MS. In Figure 1, we have shown
that pGDM without risk factors, pGDM with risk factor
(s) and pGDM with MS show higher composite cIMT
than controls (0.55±0.02 vs 0.49±0.01, 0.53±0.01 vs
0.49±0.01 and 0.54± 0.01 vs 0.49±0.01; P< 0.01, P< 0.05,
and P< 0.01, respectively), although these groups did not
differ statistically between each other (0.55±0.02 vs
0.53±0.01; 0.53±0.01 vs 0.54±0.01 and 0.55±0.02 vs
0.54±0.01; P> 0.05) and to MS (0.55±0.02 vs 0.53±0.01;
0.53±0.01 vs 0.53±0.01 and 0.54±0.01 vs 0.53±0.01;
P> 0.05 for all comparisons). The MS group also showed
higher composite cIMT than controls (0.53±0.01vs
0.49±0.01; P< 0.05).
The presence of diabetes, use of hormonal contraception
and family history of coronary disease were not statisticallydifferent between pGDM and MS groups (P> 0.05 for all
comparisons). Specifically, the prevalence of diabetes was
21.52% in pGDM vs 21.43% in MS (P> 0.05). The preva-
lence of hypertension was significantly lower in pGDM
than in MS (30.77% vs 63.33%, respectively, P< 0.01).
Antihypertensives were used in 10.11% of pGDM and in
60.01% of MS (P< 0.01), and metformin was used in
12.71% of pGDM and in 13.31% of MS (P> 0.05). Con-
cerning statins, only one patient from pGDM (1.26%) and
three patients from MS (10.00%) were using these medica-
tions (P> 0.05). None of these patients were on fibrates.
From the predictors taken as possibly related to
increased composite cIMT, all of them showed P< 0.1
by the univariate analysis (Table 3). However, only age,
total cholesterol, presence of MS and pGDM remained
in the multivariate linear regression analysis as inde-
pendent predictors with P< 0.001, P< 0.01, P< 0.05,
and P< 0.01, respectively.
Discussion
The management of GDM patients after delivery has
been considered an important issue to prevent long-
term cardiovascular diseases [2]. In the present study,
conducted in young women with predominant low FRS,
we have demonstrated that pGDM is associated with
increased cIMT, a well-established marker of subclinical
atherosclerosis, independently of other risk factors
commonly observed in this group of women. Women
with a past history of GDM had an increased cIMT in
most studied carotid segments when compared to con-
trols, but otherwise similar to a group of women with
established MS. Interestingly, our pGDM was less hyper-
tensive and obese when compared to our MS. Further-
more, pGDM also showed an increased cIMT in left
carotid bifurcation when compared to MS. It has been
shown a higher cIMT in the left common carotid than
in the right side, although not in internal carotid or
carotid bifurcation. These findings may be explained by
differences in anatomy and local shear forces, besides
bifurcations being an area of predilection for atherosclerotic
plaque formation [15,16].
This is the first study, to the best of our knowledge, to
show similar cIMT in patients with pGDM as compared to
a cohort of patients with MS, shedding new light into this
field. However, as our pGDM group was metabolically
heterogeneous, it was important to demonstrate that just a
past history of GDM is independently associated to
increased cIMT regardless of cardiometabolic status and
parity. Indeed, the stepwise model here utilized showed the
independent predictive value of pGDM for increased cIMT
alongside with other strong risk factors for atherosclerotic
disease such as age, total cholesterol, and MS [9,10].
Studies using cIMT usually refer to values applied by
standard references. In this regard, we have found that
Figure 1 Graphic representation of the differences in carotid intima-media thickness (means ± SEM) in pGDM without RF (N= 15),
pGDM with RF (N = 31), pGDM with MS (N=33), MS (N= 30), and Controls (N= 60). cIMT = carotid intima-media thickness; pGDM =
previous gestational diabetes group; RF = risk factor; MS = metabolic syndrome * P< 0.05 for comparisons to controls ** P< 0.01 for
comparisons to controls.
Freire et al. Cardiovascular Diabetology 2012, 11:59 Page 5 of 7
http://www.cardiab.com/content/11/1/59the cIMT of our Brazilian pGDM and MS groups were
above the 75th percentile when compared to European
reference values. However, if we applied the references
from North American studies [13], our patients would
be classified below the 50th percentile, underestimatingTable 3 Predictors of increased composite carotid
intima-media thickness from univariate and
multivariate stepwise linear regression analysis
Univariate analysis
Predictors Pearson Correlation P value
Age (years) 0.503 <0.001
Systolic BP (mmHg) 0.317 <0.001
Waist (cm) 0.308 <0.001
BMI (kg/m2) 0.280 0.001
Total cholesterol (mg/dl) 0.329 <0.001
LDLc(mg/dl) 0.311 <0.001
Triglycerides (mg/dl) 0.187 <0.05
Fasting Glucose (mg/dl) 0.196 <0.05
pGDM 0.296 <0.001
pGDM without MS 0.136 >0.05*
Presence of DM 0.139 >0.05*
Presence of MS 0.212 <0.05
Parity 0.281 <0.001
Multivariate analysis
Predictors Beta (95% CI) P value
Age (years) 0.431 0.003 – 0.007 <0.001
Total cholesterol (mg/dl) 0.228 0.000 - 0.001 <0.01
MS 0.196 0.007- 0.053 0.01
pGDM 0.210 0.013 – 0.076 <0.01
BP = blood pressure; BMI = body mass index; LDLc = low-density lipoprotein
cholesterol; pGDM = previous gestational diabetes group; DM = diabetes
mellitus; MS = metabolic syndrome; CI = confidence interval. * P< 0,1.their risk. Moreover, due to their young ages, they would
probably not be tested for the presence of increased
cIMT, especially those without cardiometabolic risk fac-
tors. Of note, the increase in cardiometabolic risk factors
in this group of young patients with a past history of
GDM most often did not result in a change in the FRS
towards a higher risk, minimizing possible actions on
primary prevention to these women. These data
reinforce that it is easy to underestimate the cardiovas-
cular risk in special populations when using the FRS
[5,6]. Actually, this study has shown that these young
women behave as old from a vascular point of view,
although the majority of them were classified as low risk
according to FRS.
Several studies have recently shown an increased
cardiometabolic risk profile after a pregnancy compli-
cated by GDM, mainly due to abnormalities in glucose
homeostasis. Among women with pGDM, the develop-
ment of postpartum diabetes and metabolic syndrome
has been reported as associated with increased cIMT
[17]. It is noteworthy that both our pGDM and MS
groups show average fasting glucose levels within the
range of prediabetes. However, our data show that just a
past history of GDM independently account for the
increased cIMT. Associated with disorders of glucose
metabolism it has been reported an increased prevalence
of other risk factors in these women, such as hyperten-
sion, obesity and dyslipidemia clustering as MS [3,18]. In
addition to these metabolic abnormalities, we have
previously shown that women with GDM exhibit altera-
tions on left ventricular diastolic relaxation parameters
that do not normalize after delivery, an early stage of
diabetic cardiomyopathy [19].
The silent process of atherosclerotic alterations has
been imaged by B-mode ultrasound since 1986 [20].
Since then, several studies have shown signs of early
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classic risk factors, but also in individuals free or well-
controlled for them [5,21]. The role of inflammation in
atherosclerosis has been well established over the past
ten years, and all stages of atherosclerotic plaque forma-
tion can be considered as an inflammatory response to
injury [22,23]. This relatively new concept that assigns
part of the process of development of atherosclerosis to
the presence of inflammation could possibly explain the
differences in cIMT found between the women from our
pGDM group as compared to controls, even when these
women were deprived of cardiovascular risk factors.
Accordingly, C-reactive protein has been considered a
correlate of obesity in women with GDM [24], and the
presence of inflammatory markers have been reported in
women with pGDM and increased cIMT [25,26].
Recently, Tarim et al. showed an increase in left
common cIMT in pregnant patients with GDM, inde-
pendent of fasting glucose, total cholesterol, and HDLc
[27]. Volpe et al., studying GDM patients after delivery,
reported that these women had higher mean common
cIMT, and that levels of oxidized LDL were independently
associated with cIMT, thus suggesting an inflammatory
component associated with the altered cIMT [25]. Simi-
larly, Bo et al. reported that cIMT is significantly associated
with pGDM and coupled to a higher prevalence of inflam-
matory markers [26]. Furthermore, some genetic contribu-
tion is also expected to underlie all these findings [4].
The association of IMT with atherogenic dyslipidemia,
obesity, hypertension, diabetes and MS has been well
demonstrated [7]. However, despite the possible
increased risk for atherosclerotic disease with some phe-
notypes such as MS and obesity, individuals with MS
may show signs of subclinical inflammation independ-
ently of obesity, while obese people may not present
altered metabolic profile [4,28]. Our data showed that
this Brazilian cohort of patients with previous GDM
show similar cIMT to patients with established MS inde-
pendently of the cardiometabolic profile, corroborating
with an early inflammation condition as an important
component in pGDM.
Cross-sectional studies present inherent limitations.
Other studies, enrolling larger sample sizes with other
ethnical groups, controlling for other confounders such as
uric acid [29] and renal function [30] should prospectively
contribute to confirm our findings in the future. The
present data, however, strengthens the importance of
the atherosclerotic process itself in pGDM by direct
evaluation of the arterial wall and through comparisons to
relevant groups.
The appropriate medical control of our MS group, as
observed by the absence of statistical differences in com-
parisons between pGDM and MS for blood pressure,
fasting glucose and lipid levels, despite a higherprevalence of hypertension and obesity in MS, may have
contributed to the similarities in cIMT found between
these two groups. Another relevant aspect is that the
diagnosis of GDM in this study was performed according
to Carpenter-Coustan thresholds [8] while the most
current consensus statement has recommended more
strict values for this diagnosis [1]. Thus, it is possible that
this study has selected women with pGDM who were at
higher risk for atherosclerosis thereafter.
Conclusions
We have shown that just a past history of GDM is asso-
ciated with an increased cIMT, independently of the
presence of risk factors commonly clustered in MS. The
demonstration of increased cIMT in this population,
similarly to women with altered cardiovascular risk
profile, supports an improvement of cardiovascular care
of women with gestational diabetes after delivery towards
a better cardiovascular outcome.
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